Side Effects

Do GLP-1 medications directly cause vitamin malabsorption? Dr. Joshua Silva breaks down the clinical evidence on nutrition, hair loss, and the risks of over-supplementing during weight loss. Available for telehealth across Utah.

The FDA has approved a higher weekly dose of Wegovy (semaglutide) at 7.2 mg. While clinical trials show this 3× increase can drive total body weight loss toward 20.7%, it also raises the risk of dose-dependent side effects like dysesthesia and GI distress. With no official titration guidelines yet available, Dr. Joshua Silva discusses how to approach this new dosage safely and who may benefit most from the increase.

Early research from the 2026 AAOS Annual Meeting indicates that GLP-1 medications like Ozempic and Wegovy may be associated with a higher relative risk of tendon ruptures. However, with an absolute risk increase of less than 1%, most patients remain unaffected. Discover the proposed mechanisms—from rapid activity increases to collagen signaling—and how to mitigate risk while continuing therapy.

A physician-written guide to alcohol use on GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. Covers GI side effects, blood sugar risk, altered tolerance, and emerging research on cravings.

Feeling tired on Ozempic, Wegovy, or Zepbound? Fatigue is a documented side effect affecting up to 11% of patients. Explore the physiological reasons behind GLP-1 fatigue and learn evidence-based management strategies—like optimizing hydration and protein intake—with Dr. Joshua Silva, MD.

Is it safe to breastfeed while taking Ozempic® or Mounjaro®? While limited data suggests low transfer into breast milk, official FDA guidance remains cautious due to unknown long-term risks. Learn about the science of peptide transfer, washout periods, and why most clinicians recommend discontinuing GLP-1s during lactation.

Diarrhea is a common but usually temporary side effect of GLP-1 medications like Wegovy® and Zepbound®. This physician-reviewed guide explains why it happens, food triggers, dose considerations, and when symptoms need medical attention.

Constipation is a common side effect of GLP-1 medications like semaglutide and tirzepatide. Learn why it happens, how to fix it safely, and when to seek medical care.

Are sulfur burps and bloating ruining your GLP-1 progress? Many patients turn to digestive enzymes for relief, but the science shows a "mechanism mismatch." Discover why enzymes often fail to fix the "traffic jam" in your stomach—and when they might actually be worth a try.

Experiencing sulfur burps or a "stuck" feeling on Ozempic? Dr. Joshua Silva, MD explains the science of delayed gastric emptying and offers 6 actionable tips to reduce gas and bloating.

Nausea is one of the most common side effects of GLP-1 medications like Wegovy® and Zepbound®. Learn what foods help, what to avoid, and how simple timing and dosing strategies can improve tolerability.

GLP-1 and GLP-1/GIP medications like semaglutide and tirzepatide don’t cause true muscle wasting. Most weight lost is fat, not muscle. Learn how proper protein intake and resistance training preserve lean mass and support healthy body composition during GLP-1 therapy.

Worried about hair loss while taking Wegovy®, Ozempic® (semaglutide), Zepbound®, or Mounjaro® (tirzepatdie)? Learn why shedding happens during weight loss and how to prevent it.